The suitability of survival data from randomised controlled trials (RCTs) for meta-analysis

Survival analyses based on data from oncology randomised controlled trials (RCTs) provide key evidence for decision-making on treatment options for cancer. In the second of our DRG investigative series, we review the methods and reporting of survival analyses in oncology RCTs and assess the suitability and relevance of survival data reported in RCTs for inclusion into meta-analysis


We are part of Clarivate, a global leader in providing trusted insights and analytics to accelerate the pace of innovation.

Our Company
© DRG Abacus 2021